Business Commons^™

Personalized Medicine: The Use Of Biomarkers And Molecularly Targeted Therapies For Patient Care And Cancer Intervention, Wafa Asad, Emily Schmitt Lavin

Mako: NSU Undergraduate Student Journal

Personalized medicine and targeted therapy have been emerging fields of study for the remediation and inhibition of cancer. Personalized medicine in the treatment of cancer involves using genetic, immune, and proteomic profiling to provide therapeutic options as well as prognostic background for every patient and their tumor’s genetic mutations. Targeted therapies allow researchers and medical personnel alike to determine the appropriate treatment for a patient based on the molecular basis and mechanistic actions of a cancerous tumor. The overall significance of this study was to express how these treatments use biomarkers to pinpoint the location, and severity of the cancer, …

The Cost Of Cancer In Southwest Georgia- 2001, John G. Kooti, Philip I. Szmedra

Southern Business Review

John G. Kooti, PhD, is professor and dean, School of Business Administration, Georgia Southwestern State University, Americus, GA 31709.

Phillip I. Szmedra, PhD, is assistant professor of economics, School of Arts and Sciences, Georgia Southwestern State University, Americus, GA 31709.

Barn-Raising On The Digital Frontier: The L.A.U.N.C.H. Collaborative, Bradford W. Hesse, David Ahern, Michele Ellison, Eliah Aronoff-Spencer, Robin C. Vanderpool, Karen Onyeije, Michael C. Gibbons, Timothy W. Mullett, Ming-Yuan Chih, Victoria Attencio, Grant Patterson, Jessica Boten, Christopher Hartshorn, Ben Bartolome, Katie Gorscak, Melanie Mccomsey, Alexandra Hubenko, Bin Huang, Corey Baker, Don Norman

Journal of Appalachian Health

A meta-analysis of oncology papers from around the world revealed that cancer patients who lived more than 50 miles away from hospital centers routinely presented with more advanced stages of disease at diagnosis, exhibited lower adherence to prescribed treatments, presented with poorer diagnoses, and reported a lower quality of life than patients who lived nearer to care facilities. Connected health approaches—or the use of broadband and telecommunications technologies to evaluate, diagnose, and monitor patients beyond the clinic—are becoming an indispensable tool in medicine to overcome the obstacle of distance.

Lymphoma: Exploring Awareness In Lebanon, Nariman Salem, Lena Abou Merhi, Ghwia Adra, Rayan Ayoub, Nour El-Akash, Sara Chaar, Adeeb Awad Awad, Omar Dasuki,

BAU Journal - Health and Wellbeing

In 2012, 14.1 million patients were diagnosed with cancer worldwide of which 385,700 estimated new cases of non-Hodgkin lymphoma (NHL). Also, 81,080 new cases of lymphoma were reported in the United States (US) among both genders in 2016. In Lebanon, Lymphoma represents the fifth most frequent cancer, nonetheless, little is known regarding its epidemiological attributes. This study aims to determine the current knowledge of the Lebanese people living in Lebanon about Lymphoma. About 400 participants were approached in public places, universities, hospitals or work places in different regions across Lebanon. A survey including questions about lymph nodes, cancer and lymphoma …